List view / Grid view

Jessica Flechtner (Genocea)

 

article

Neoantigens: presenting new vaccine opportunities in immuno-oncology

Neoantigens have gained much interest in recent years, mainly due…

4 June 2020 | By

Neoantigens have gained much interest in recent years, mainly due to their ability to elicit a strong, specific immune response. Nikki Withers spoke to two immunology experts to explore the progress being made and assess what remains challenging for cancer investigators working on these transformational therapies.